Chemoinformaics analysis of Methyl 2-methylhexacosanoate
Molecular Weight | 424.754 | nRot | 24 |
Heavy Atom Molecular Weight | 368.306 | nRig | 24 |
Exact Molecular Weight | 424.428 | nRing | 0 |
Solubility: LogS | -3.448 | nHRing | 0 |
Solubility: LogP | 1.94 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 85.7044 |
nHD | 0 | BPOL | 58.7836 |
QED | 0.811 |
Synth | 5.844 |
Natural Product Likeliness | 1.808 |
NR-PPAR-gamma | 0.184 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.063 |
Pgp-sub | 0.527 |
HIA | 0.008 |
CACO-2 | -5.008 |
MDCK | 0.0000225 |
BBB | 0.993 |
PPB | 0.436098 |
VDSS | 6 |
FU | 0.549147 |
CYP1A2-inh | 0.05 |
CYP1A2-sub | 0.198 |
CYP2c19-inh | 0.036 |
CYP2c19-sub | 0.927 |
CYP2c9-inh | 0.018 |
CYP2c9-sub | 0.104 |
CYP2d6-inh | 0.775 |
CYP2d6-sub | 0.89 |
CYP3a4-inh | 0.245 |
CYP3a4-sub | 0.784 |
CL | 5.17 |
T12 | 0.07 |
hERG | 0.341 |
Ames | 0.256 |
ROA | 0.874 |
SkinSen | 0.226 |
Carcinogencity | 0.933 |
EI | 0.011 |
Respiratory | 0.984 |
NR-Aromatase | 0.878 |
Antiviral | Yes |
Prediction | 0.523485 |